Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 238

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 238
---
 accounts receivable
           
          $
          29,563

          100.0
          %
           
          $
          42,241

          100.0
          %
         
         The following table sets forth the accounts receivable allowances as of December 31, 2024 and December 31, 2023: 

          As of

          As of

          December 31, 2024

          December 31, 2023

          Allowances - accounts receivable
           
          $

          %

          $

          %

          Doubtful accounts
           
          $
          458

          1.5
          %
           
          $
          2,341

          5.2
          %

          Sales returns

          413

          1.4
          %

          479

          1.1
          %

          Total allowances - accounts receivable
           
          $
          871

          2.9
          %
           
          $
          2,820

          6.3
          %

 F-16

Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash, cash equivalents, marketable securities, financing receivable and accounts receivable. At times, cash account balances may be in excess of the amounts insured by the Federal Deposit Insurance Corporation. However, management believes the risk of loss to be minimal. The Company performs periodic evaluations of the relative credit standing of these institutions and has not experienced any losses on its cash and cash equivalents to date. The Company has also entered into hedging relationships with a single counterparty to offset the forecasted Euro-based revenues. The credit risk has been reduced due to a net settlement arrangement whereby the Company is allowed to net settle transactions with a single net amount payable by one party to the other.Financing receivableThe Company's credit terms are predominately short term in nature from delivery of the product or invoicing. However, in certain circumstances, the Company offers extended payment terms to customers who have not met the payment terms of their original contract. In addition, certain customers may not comply with formal payment terms specified in their written agreements with us. When the period between the transfer of control of the products and payment is expected to be greater than one year, the Company will adjust the promised amount of consideration for the effects of a significant financing component. When contracts contain a significant financing component in which the Company is effectively financing